CLINICAL_TRIALS ClinicalTrials.gov record update

ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03338816
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:49.247405+00:00
Published At: 2020-02-11T00:00:00+00:00
Record Updated At: 2024-04-22
Results Posted At: 2020-02-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute Hepatic Porphyria", "Acute Intermittent Porphyria", "Porphyria, Acute Intermittent", "Acute Porphyria", "Hereditary Coproporphyria (HCP)", "Variegate Porphyria (VP)", "ALA Dehydratase Deficient Porphyria (ADP)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-04-22"
protocolSection.identificationModule.nctId: "NCT03338816"
protocolSection.identificationModule.officialTitle: "ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-02-11"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.